We are live on ! Find out more
GMED icon

Globus Medical

137 hedge funds and large institutions have $1.05B invested in Globus Medical in 2013 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 58 increasing their positions, 36 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

121% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 14

61% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 36

17% more capital invested

Capital invested by funds: $899M → $1.05B (+$149M)

14% more funds holding

Funds holding: 120137 (+17)

0.57% more ownership

Funds ownership: 78.79%79.36% (+0.57%)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $79K

Holders
137
Holders Change
+17
Holders Change %
+14.17%
% of All Funds
3.98%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
31
Increased
58
Reduced
36
Closed
14
Calls
Puts
$79K
Net Calls
-$79K
Net Calls Change
-$184K
Name Holding Trade Value Shares
Change
Change in
Stake
NC
26
Northpointe Capital
Michigan
$12.8M +$6.37M +342,935 +118%
KCM
27
Kennedy Capital Management
Missouri
$12.6M +$314K +16,919 +3%
Bank of Montreal
28
Bank of Montreal
Ontario, Canada
$11.8M +$10.9M +585,752 New
T. Rowe Price Associates
29
T. Rowe Price Associates
Maryland
$10.9M -$15.9M -858,866 -61%
AP
30
AlpInvest Partners
Netherlands
$10.8M -$752K -40,490 -7%
EAM
31
Eagle Asset Management
Florida
$10.7M +$7.17M +386,006 +270%
PAMP
32
Polar Asset Management Partners
Ontario, Canada
$9.83M +$835K +45,000 +10%
RFC
33
Russell Frank Company
Washington
$9.83M +$1.28M +68,953 +19%
SBH
34
Segall Bryant & Hamill
Illinois
$9.41M +$8.65M +466,171 New
Geode Capital Management
35
Geode Capital Management
Massachusetts
$7.05M +$1.68M +90,673 +35%
Wells Fargo
36
Wells Fargo
California
$6.77M +$202K +10,883 +3%
Arrowstreet Capital
37
Arrowstreet Capital
Massachusetts
$6.74M +$5.08M +273,397 +451%
VAM
38
Visium Asset Management
New York
$6.24M +$2.02M +108,716 +54%
GT
39
Glenmede Trust
Pennsylvania
$6.15M -$241K -13,000 -4%
GG
40
Gofen & Glossberg
Illinois
$6.02M -$1.13M -61,000 -17%
CCM
41
Cadence Capital Management
Massachusetts
$5.74M +$5.28M +284,224 New
Renaissance Technologies
42
Renaissance Technologies
New York
$5.52M +$5.08M +273,600 New
Bank of America
43
Bank of America
North Carolina
$5.36M +$267K +14,408 +6%
PRCM
44
Pine River Capital Management
Minnesota
$5.18M +$2.62M +141,275 +122%
CII
45
CR Intrinsic Investors
Connecticut
$5.04M -$464K -25,000 -9%
MSA
46
Mason Street Advisors
Wisconsin
$4.41M +$821K +44,250 +25%
TCIM
47
TIAA CREF Investment Management
New York
$4.32M -$97.6K -5,258 -2%
Allianz Asset Management
48
Allianz Asset Management
Germany
$4.31M -$121K -6,545 -3%
NTCOC
49
Northern Trust Company of Connecticut
Connecticut
$4.01M -$211K -11,340 -5%
NC
50
Nicholas Company
Wisconsin
$4M

GMED Hedge Fund Activity: Q4 2013 in Review

137 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Globus Medical (GMED) for Q4 2013, worth a combined $1.05B — up 17% from $899M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new GMED positions and 14 closed out — a net gain of 17 holders — while 58 added to existing stakes and 36 trimmed.

The largest buyer was Loomis, Sayles & Company, adding an estimated $16.7M. The largest seller was Goldman Sachs, cutting an estimated $110M.

  • 137 institutional investors held Globus Medical (GMED) as of Q4 2013, up from 120 in Q3 2013.
  • Funds reported $1.05B of Globus Medical stock for Q4 2013, up 17% quarter-over-quarter.
  • 31 funds opened new Globus Medical positions in Q4 2013 and 14 closed out, a net change of +17 holders.
  • The largest Globus Medical buyer in Q4 2013 was Loomis, Sayles & Company, an estimated $16.7M added.
  • The largest Globus Medical seller in Q4 2013 was Goldman Sachs, an estimated $110M sold.

Based on aggregated 13F filings for Q4 2013.